Impro Precision Industries (1286) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
19 Aug, 2026Executive summary
Group revenue rose 23.2% year-over-year to HK$3,018.0 million for 1H/2026, driven by strong demand in AI, data centers, energy, and diversified industrials end-markets.
Adjusted profit attributable to shareholders increased 20.4% to HK$433.1 million; EBITDA up 15.8% to HK$828.4 million.
Interim dividend maintained at 8.0 HK cents per share, totaling approximately HK$155.8 million.
Growth was led by high horsepower engines, liquid cooling systems for AI/data centers, and robust energy and aerospace sectors.
Challenges included ramp-up costs at the Mexico SLP Campus, Turkish plant profit decline from inflation and weak European auto demand, and foreign exchange losses.
Financial highlights
Gross profit increased 25.7% to HK$856.8 million; gross margin improved to 28.4%.
EBITDA margin at 27.4%; adjusted EPS rose 19.4% to 22.80 HK cents.
Net cash from operating activities up 24.1% to HK$689.1 million; cash and cash equivalents at HK$1,248.4 million as of June 30, 2026.
Market capitalization grew 70.1% to HK$15,636.7 million; net gearing ratio improved to 18.3%.
Americas accounted for 48.4% of revenue, Asia 27.9%, Europe 23.7%.
Outlook and guidance
Full-year 2026 sales growth forecast raised to 20–25% year-over-year, supported by strong order backlog, AI/data center demand, and Mexico SLP Campus ramp-up.
Anticipates robust growth in diversified industrials, aerospace, energy, and medical sectors; automotive sector expected to recover as new projects enter mass production.
Ample liquidity with ~HK$1.2B cash and HK$2.6B undrawn banking facilities to support expansion and potential M&A.
Targeting to double total revenue to over HK$10 billion by 2029/2030.
Latest events from Impro Precision Industries
- Record profit and revenue growth led by medical and AI sectors, with strong outlook and robust cash flow.1286
H2 2025 - Adjusted profit rose 11.6% on 2.0% revenue growth, led by high horsepower engine and medical segments.1286
H1 2025 - Adjusted profit up 3.6% on stable revenue, led by high horsepower engine and aerospace growth.1286
H1 2024 - High horsepower engine and aerospace drove profit and margin growth, with robust 2025 outlook.1286
H2 2024